( Moreover ( , ( ( individuals ( with ( ( compromised ( lung status ) ) ( such ( as ( patients ( with ( chronic ( obstructive ( pulmonary disease ) ) ) ) ) ) ) ) ) ) ( likely ( ( have ( ( ( significantly higher ) numbers ) ( of ( particles ( arriving ( at ( ( each ( functional alveolus ) ) ( than ( normal individuals ) ) ) ) ) ) ) ) ) . ) ) ) ) )
(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (NNS individuals)) (PP (IN with) (NP (NP (VBN compromised) (NN lung) (NN status)) (PP (JJ such) (IN as) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ chronic) (JJ obstructive) (JJ pulmonary) (NN disease)))))))) (ADVP (RB likely)) (VP (VBP have) (NP (NP (ADJP (RB significantly) (JJR higher)) (NNS numbers)) (PP (IN of) (NP (NP (NNS particles)) (VP (VBG arriving) (PP (IN at) (NP (NP (DT each) (ADJP (JJ functional)) (NNS alveolus)) (PP (IN than) (NP (JJ normal) (NNS individuals)))))))))) (. .)))
Moreover, individuals with compromised lung status such as patients with chronic obstructive pulmonary disease likely have significantly higher numbers of particles arriving at each functional alveolus than normal individuals.
(ROOT (S (NP (NP (DT The) (NNS lungs)) (PP (IN of) (NP (NNS mammals)))) (VP (VBP are) (ADJP (JJ unique) (PP (IN in) (S (VP (VBG having) (NP (NNS alveoli))))))) (. .)))